Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.24 | 0.0003 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 0.002 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.15 | 0.008 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.15 | 0.02 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.13 | 0.03 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.13 | 0.03 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.11 | 0.04 |